[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Vaccine Adjuvants-United States Market Status and Trend Report 2013-2023

December 2017 | 146 pages | ID: V75CBD3D687EN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Vaccine Adjuvants-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vaccine Adjuvants industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole United States and Regional Market Size of Vaccine Adjuvants 2013-2017, and development forecast 2018-2023
Main market players of Vaccine Adjuvants in United States, with company and product introduction, position in the Vaccine Adjuvants market
Market status and development trend of Vaccine Adjuvants by types and applications
Cost and profit status of Vaccine Adjuvants, and marketing status
Market growth drivers and challenges

The report segments the United States Vaccine Adjuvants market as:

United States Vaccine Adjuvants Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

New England
The Middle Atlantic
The Midwest
The West
The South
Southwest

United States Vaccine Adjuvants Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Oral
Subcutaneous
Intramuscular
Others

United States Vaccine Adjuvants Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Human Vaccine Adjuvants
Research Applications
Commercial Applications

United States Vaccine Adjuvants Market: Players Segment Analysis (Company and Product introduction, Vaccine Adjuvants Sales Volume, Revenue, Price and Gross Margin):

Brenntag Biosector
Seppic
CSL Limited
Agenus
Novavax
Invivogen
SPI Pharma
Avanti Polar Lipids
MPV Technologies
OZ Biosciences

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

CHAPTER 1 OVERVIEW OF VACCINE ADJUVANTS

1.1 Definition of Vaccine Adjuvants in This Report
1.2 Commercial Types of Vaccine Adjuvants
  1.2.1 Oral
  1.2.2 Subcutaneous
  1.2.3 Intramuscular
  1.2.4 Others
1.3 Downstream Application of Vaccine Adjuvants
  1.3.1 Human Vaccine Adjuvants
  1.3.2 Research Applications
  1.3.3 Commercial Applications
1.4 Development History of Vaccine Adjuvants
1.5 Market Status and Trend of Vaccine Adjuvants 2013-2023
  1.5.1 United States Vaccine Adjuvants Market Status and Trend 2013-2023
  1.5.2 Regional Vaccine Adjuvants Market Status and Trend 2013-2023

CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Vaccine Adjuvants in United States 2013-2017
2.2 Consumption Market of Vaccine Adjuvants in United States by Regions
  2.2.1 Consumption Volume of Vaccine Adjuvants in United States by Regions
  2.2.2 Revenue of Vaccine Adjuvants in United States by Regions
2.3 Market Analysis of Vaccine Adjuvants in United States by Regions
  2.3.1 Market Analysis of Vaccine Adjuvants in New England 2013-2017
  2.3.2 Market Analysis of Vaccine Adjuvants in The Middle Atlantic 2013-2017
  2.3.3 Market Analysis of Vaccine Adjuvants in The Midwest 2013-2017
  2.3.4 Market Analysis of Vaccine Adjuvants in The West 2013-2017
  2.3.5 Market Analysis of Vaccine Adjuvants in The South 2013-2017
  2.3.6 Market Analysis of Vaccine Adjuvants in Southwest 2013-2017
2.4 Market Development Forecast of Vaccine Adjuvants in United States 2018-2023
  2.4.1 Market Development Forecast of Vaccine Adjuvants in United States 2018-2023
  2.4.2 Market Development Forecast of Vaccine Adjuvants by Regions 2018-2023

CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES

3.1 Whole United States Market Status by Types
  3.1.1 Consumption Volume of Vaccine Adjuvants in United States by Types
  3.1.2 Revenue of Vaccine Adjuvants in United States by Types
3.2 United States Market Status by Types in Major Countries
  3.2.1 Market Status by Types in New England
  3.2.2 Market Status by Types in The Middle Atlantic
  3.2.3 Market Status by Types in The Midwest
  3.2.4 Market Status by Types in The West
  3.2.5 Market Status by Types in The South
  3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Vaccine Adjuvants in United States by Types

CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Vaccine Adjuvants in United States by Downstream Industry
4.2 Demand Volume of Vaccine Adjuvants by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Vaccine Adjuvants by Downstream Industry in New England
  4.2.2 Demand Volume of Vaccine Adjuvants by Downstream Industry in The Middle Atlantic
  4.2.3 Demand Volume of Vaccine Adjuvants by Downstream Industry in The Midwest
  4.2.4 Demand Volume of Vaccine Adjuvants by Downstream Industry in The West
  4.2.5 Demand Volume of Vaccine Adjuvants by Downstream Industry in The South
  4.2.6 Demand Volume of Vaccine Adjuvants by Downstream Industry in Southwest
4.3 Market Forecast of Vaccine Adjuvants in United States by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VACCINE ADJUVANTS

5.1 United States Economy Situation and Trend Overview
5.2 Vaccine Adjuvants Downstream Industry Situation and Trend Overview

CHAPTER 6 VACCINE ADJUVANTS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES

6.1 Sales Volume of Vaccine Adjuvants in United States by Major Players
6.2 Revenue of Vaccine Adjuvants in United States by Major Players
6.3 Basic Information of Vaccine Adjuvants by Major Players
  6.3.1 Headquarters Location and Established Time of Vaccine Adjuvants Major Players
  6.3.2 Employees and Revenue Level of Vaccine Adjuvants Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 VACCINE ADJUVANTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Brenntag Biosector
  7.1.1 Company profile
  7.1.2 Representative Vaccine Adjuvants Product
  7.1.3 Vaccine Adjuvants Sales, Revenue, Price and Gross Margin of Brenntag Biosector
7.2 Seppic
  7.2.1 Company profile
  7.2.2 Representative Vaccine Adjuvants Product
  7.2.3 Vaccine Adjuvants Sales, Revenue, Price and Gross Margin of Seppic
7.3 CSL Limited
  7.3.1 Company profile
  7.3.2 Representative Vaccine Adjuvants Product
  7.3.3 Vaccine Adjuvants Sales, Revenue, Price and Gross Margin of CSL Limited
7.4 Agenus
  7.4.1 Company profile
  7.4.2 Representative Vaccine Adjuvants Product
  7.4.3 Vaccine Adjuvants Sales, Revenue, Price and Gross Margin of Agenus
7.5 Novavax
  7.5.1 Company profile
  7.5.2 Representative Vaccine Adjuvants Product
  7.5.3 Vaccine Adjuvants Sales, Revenue, Price and Gross Margin of Novavax
7.6 Invivogen
  7.6.1 Company profile
  7.6.2 Representative Vaccine Adjuvants Product
  7.6.3 Vaccine Adjuvants Sales, Revenue, Price and Gross Margin of Invivogen
7.7 SPI Pharma
  7.7.1 Company profile
  7.7.2 Representative Vaccine Adjuvants Product
  7.7.3 Vaccine Adjuvants Sales, Revenue, Price and Gross Margin of SPI Pharma
7.8 Avanti Polar Lipids
  7.8.1 Company profile
  7.8.2 Representative Vaccine Adjuvants Product
  7.8.3 Vaccine Adjuvants Sales, Revenue, Price and Gross Margin of Avanti Polar Lipids
7.9 MPV Technologies
  7.9.1 Company profile
  7.9.2 Representative Vaccine Adjuvants Product
  7.9.3 Vaccine Adjuvants Sales, Revenue, Price and Gross Margin of MPV Technologies
7.10 OZ Biosciences
  7.10.1 Company profile
  7.10.2 Representative Vaccine Adjuvants Product
  7.10.3 Vaccine Adjuvants Sales, Revenue, Price and Gross Margin of OZ Biosciences

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VACCINE ADJUVANTS

8.1 Industry Chain of Vaccine Adjuvants
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VACCINE ADJUVANTS

9.1 Cost Structure Analysis of Vaccine Adjuvants
9.2 Raw Materials Cost Analysis of Vaccine Adjuvants
9.3 Labor Cost Analysis of Vaccine Adjuvants
9.4 Manufacturing Expenses Analysis of Vaccine Adjuvants

CHAPTER 10 MARKETING STATUS ANALYSIS OF VACCINE ADJUVANTS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications